home / stock / cydy / cydy news

CYDY News and Press, CytoDyn Inc From 03/08/20

Stock Information
Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com
Menu
CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...
CYDY - CytoDyn Files IND and Protocol for Phase 2 Clinical Trial for Treatment of Patients with Coronavirus with Leronlimab (PRO 140)

Coronavirus Can Quickly Progress to Severe Pneumonia and Even Death Due to Immune Hyperactivity Including Acute Respiratory Distress Syndrome (ARDS); CytoDyn's Trial Focuses on Patients Who Develop Mild-To-Moderate Respiratory Illness After Contracting Coronavirus CytoDyn Negotiating ...
CYDY - CytoDyn to Hold Conference Call for Updates on Filing Phase 2 Trial with FDA for Treatment of Coronavirus in U.S., Status of BLA, Breakthrough Therapy Designation, Basket Trial for 22 Solid Tumor Cancers and Licensing Opportunities in Several Countries

VANCOUVER, Washington, Feb. 28, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced t...

CYDY - Meet Today's Innovators: Digital Celebrities, Augmented Reality, 3D Advertising, AR E-Commerce, and Biotech Breakthroughs in Cancer, HIV therapy (and potential coronavirus treatment)

NEW YORK, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published news and CEO Interview updates with the innovative companies which presented at the highly acclaimed “NEXT SUPER STOCK Live!” conference series. The V...

CYDY - Investment Experts discuss "Coronavirus Stocks" in an interview with Wall Street Reporter

NEW YORK, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published exclusive interviews with top-performing investment experts Dr. Joe Duarte, MD., publisher of “In The Money Options” and Crista Huff, lead analyst at&...
CYDY - CytoDyn Receives Institutional Review Board Approval to Initiate Phase 2 Basket Trial for 22 Solid Tumor Cancers

Results from mTNBC and MBC studies continues to be positive with the first patient now at almost five months of treatment showing zero CTC, EMT and CAML. Seven patients have been enrolled to date VANCOUVER, Washington, Feb. 21, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (&#...

CYDY - CytoDyn Interview to Air on Bloomberg International on the RedChip Money Report

VANCOUVER, Washington, Feb. 20, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced t...

CYDY - "Digital Humans", Augmented Reality and Biotech Breakthroughs in Cancer and HIV therapy

“NEXT SUPER STOCK” Conference presentation videos from: FaceBank Group, INC (OTC: FBNK) CytoDyn Inc. (OTC: CYDY) NexTech AR Solutions Corp. (OTC: NEXCF) Imagination Park Technologies, Inc. (OTC: IPNFF) NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Wall Street Reporter, ...
CYDY - CytoDyn Reports Continued Positive Clinical Data on its Phase 1b/2 mTNBC and Expanded Access Studies for MBC Ahead of Breakthrough Therapy Designation Decision From the FDA

VANCOUVER, Washington, Feb. 14, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced...

CYDY - CytoDyn Signs Letter of Intent for the Joint Development and Licensing of Leronlimab in China with Longen China Group

VANCOUVER, Washington, Feb. 12, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced...

CYDY - Best Penny Stocks To Watch Before Next Week? 1 Up Over 70% This Year

Investing in penny stocks is often regarded as an effective way for new investors to make money in the market. It’s also a way to leverage small amounts of capital to make large windfalls. I won’t bore you with the details of how to make money with penny stocks. Honestly, it ...
Previous 10 Next 10